You must be logged in and verified to contact the designer.
Product Description
The variant Hemoglobin ζ2 β2 that is formed from sickle hemoglobin (α2β2-s) by exchanging adult α-globin with embryonic ζ-globin subunits shows promise as a therapeutic agent for sickle-cell disease (SCD). Hemoglobin ζ2β2 inhibits the polymerization of deoxygenated Hb S in vitro and reverses characteristic features of SCD in vivo in mouse models of the disorder.
We're sorry to inform you that we no longer support this browser and can't confirm that everything will work as expected. For the best Shapeways experience, please use one of the following browsers: